Markets:

Overview

News

Currencies

International

Treasuries

Infinity Pharmaceuticals, Inc. - Common Stock (NQ:INFI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Infinity Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >

This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday ↗

August 17, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 10, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 10, 2022

Via Benzinga

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 10, 2022

Gainers

Via Benzinga

Infinity Pharmaceuticals: Q2 Earnings Insights ↗

August 09, 2022

Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 09, 2022

Via Benzinga

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session ↗

August 10, 2022

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

Via Benzinga

Infinity Pharmaceuticals's Return On Capital Employed Insights ↗

May 13, 2022

Benzinga Pro data, Infinity Pharmaceuticals (NASDAQ:INFI) reported Q1 sales of $652.00 thousand. Earnings fell to a loss of $12.44 million, resulting in a 6.74% decrease from last quarter.

Via Benzinga

70 Biggest Movers From Friday ↗

May 31, 2022

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...

Via Benzinga

Infinity Pharmaceuticals: Q1 Earnings Insights ↗

May 03, 2022

Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

81 Biggest Movers From Yesterday ↗

May 18, 2022

Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.

Via Benzinga

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗

May 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

99 Biggest Movers From Yesterday ↗

May 12, 2022

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.

Via Benzinga

Infinity Pharmaceuticals Earnings Preview ↗

May 02, 2022

Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

51 Biggest Movers From Yesterday ↗

March 31, 2022

Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 30, 2022

Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0...

Via Benzinga

Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

March 30, 2022

Infinity Pharmaceuticals (NASDAQ:INFI) brought in sales totaling $451.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.76%, resulting in a loss of $11.65...

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

Infinity Pharmaceuticals Earnings Preview ↗

March 28, 2022

Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

50 Biggest Movers From Yesterday ↗

January 06, 2022

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 05, 2022

Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...

Via Benzinga

Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial ↗

December 10, 2021

Infinity Pharmaceuticals Inc (NASDAQ: INFI) presented updated data from the ongoing MARIO-3 study during the 2021 San Antonio Breast Cancer Symposium (SABCS)....

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 10, 2021

Gainers Reshape Lifesciences (NASDAQ:RSLS...

Via Benzinga

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré ↗

December 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...

Via Benzinga

Infinity Pharmaceuticals's Return On Capital Employed Insights ↗

November 02, 2021

According to data from Benzinga Pro, during Q2, Infinity Pharmaceuticals's (NASDAQ:INFI) reported sales totaled $512.00 thousand. Despite a 2.86% increase in earnings, the company...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today ↗

October 18, 2021

An analyst initiated coverage of the biotech stock with a unambiguous buy recommendation.

Via The Motley Fool

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

August 09, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 03, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Infinity Pharmaceuticals, Inc. - Common Stock (NQ:INFI)

Headline News about Infinity Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today